Preliminary program

 

Title to be determined

 

8:00 AM     Registration Desk opens
8:50 AM Welcome from Organizers
  Session 1 – CAR engineering and therapy
  Chair: Elie Haddad
9:00 AM

Naoto Hirano, Université of Toronto

9:45 AM Elie Haddad, CRCHUSJ and Université de Montréal
10:05 AM Henrique Bittencourt, CRCHUSJ and Université de Montréal
10:20 – 10:40 Coffee break
  Session 2 – Genome editing
 

Chair: Fabien Touzot

10:40 AM Yannick Doyon, Université Laval
11:15 AM

Natacha Merindol

CRISPR-Cas9-mediated edition of the human TRIM5 gene increases the resistance of Jurkat T lymphocytic cells to HIV-1 infection
11:30 AM

Antoine Guyon

Base editing strategy allows high frequency insertion of the protective A673T mutation in the APP gene to prevent the development of Alzheimer's disease
11:45 – 2:00 PM Poster presentation and lunch
  Session 3 – Vectors
  Chair: Christian Beauséjour
2:00 PM Rénald Gilbert, Conseil national de recherches Canada  
2:35 PM Olivier Negre, Bluebird, Boston, USA

3:05 PM

William Lemieux
A Baboon Envelope to transduce NK cells
3:20 – 3:40 PM Coffee break
  Session 4 – Clinical gene therapy
  Chair: Elie Haddad
3:40 PM Don Kohn, UCLA, USA
4:25 PM Erik Mena
cGMP viral vector manufacturing: the challenge from bench to bedside
4:40 PM

Martin Barbier
Gene therapy and tissue engineering: a strategy to treat recessive dystrophic epidermolysis bullosa

4:55 Closing remarks